Biotron Limited is an Australian biotechnology company committed to the development and commercialization of novel therapeutics and diagnostics to address a range of significant health issues.
Biotron's focus is on development of novel antiviral therapeutics and high-throughput screening technologies for cancer diagnosis. In addition, the Company is pursuing a number of early-stage projects targeting other indications such as cardiovascular disease.
For more information please e-mail enquiries@biotron.com.au
